Transcatheter Aortic Valve Replacement in Nonsurgical Candidates With Severe, Symptomatic Aortic Stenosis: A Cost-Effectiveness Analysis [Original Articles]
Conclusions—
TAVR seems to be an effective but somewhat expensive alternative to medical management among patients with symptomatic aortic stenosis ineligible for surgery. TAVR is more cost-effective for patients with a lower burden of noncardiac disease.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Simons, C. T., Cipriano, L. E., Shah, R. U., Garber, A. M., Owens, D. K., Hlatky, M. A. Tags: Health policy and outcome research Original Articles Source Type: research
More News: Aortic Stenosis | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Healthcare Costs | Heart | Heart Valve Surgery | Hospital Management | Stroke